ZAG has also been shown to suppress the growth of oral and pancreatic cancer by downregulating cyclin-dependent kinase 1 gene and inducing mesenchymal-to-epithelial transdifferentiation, respectively (71, 72). The gene discussed is CDK1; the disease is pancreatic neoplasm.